Sign Out
Should not be administered to patients with known hypersensitivity to other sympathomimetic drugs (i.e. ephedrine, phenylpropanolamine HCl, phenylephrine), patients with severe hypertension, and patients receiving antidepressant therapy like monoamine oxidase (MAO) inhibitors.
Do not exceed the recommended dosage.
Use with caution in hypertensive patients or those who are potentially predisposed to hypertension or stroke, such as overweight or geriatric patients.
If symptoms persist within 3 days, consult a physician or medical service unit.
Stop using this medicine in case of insomnia, palpitation or headache.
Lanjutkan dengan Google